Five-year PFS from the AETHERA trial of brentuximab vedotin for Hodgkin lymphoma at high risk of progression or relapse von Moskowitz, Craig H., Walewski, Jan, Nademanee, Auayporn, Masszi, Tamas, Agura, Edward, Holowiecki, Jerzy, Abidi, Muneer H., Chen, Andy I., Stiff, Patrick, Viviani, Simonetta, Bachanova, Veronika, Sureda, Anna, McClendon, Teresa, Lee, Connie, Lisano, Julie, Sweetenham, John

Volltext

Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomise... von Moskowitz, Craig H, Dr Prof, Nademanee, Auayporn, Prof, Masszi, Tamas, Prof, Agura, Edward, Prof, Holowiecki, Jerzy, Prof, Abidi, Muneer H, Prof, Chen, Andy I, Prof, Stiff, Patrick, Prof, Gianni, Alessandro M, Prof, Carella, Angelo, Prof, Osmanov, Dzhelil, Prof, Bachanova, Veronika, Prof, Sweetenham, John, Prof, Sureda, Anna, Prof, Huebner, Dirk, MD, Sievers, Eric L, MD, Chi, Andy, PhD, Larsen, Emily K, MS, Hunder, Naomi N, MD, Walewski, Jan, Prof

Volltext

Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a r... von Hermine, Olivier, Prof, Hoster, Eva, PhD, Walewski, Jan, MD, Bosly, André, MD, Stilgenbauer, Stephan, MD, Thieblemont, Catherine, MD, Szymczyk, Michal, MD, Bouabdallah, Reda, MD, Kneba, Michael, Prof, Hallek, Michael, Prof, Salles, Gilles, Prof, Feugier, Pierre, MD, Ribrag, Vincent, MD, Birkmann, Josef, MD, Forstpointner, Roswitha, MD, Haioun, Corinne, MD, Hänel, Mathias, MD, Casasnovas, René Olivier, MD, Finke, Jürgen, MD, Peter, Norma, MD, Bouabdallah, Kamal, MD, Sebban, Catherine, MD, Fischer, Thomas, Prof, Dührsen, Ulrich, Prof, Metzner, Bernd, MD, Maschmeyer, Georg, MD, Kanz, Lothar, Prof, Schmidt, Christian, MD, Delarue, Richard, MD, Brousse, Nicole, MD, Klapper, Wolfram, MD, Macintyre, Elizabeth, Prof, Delfau-Larue, Marie-Hélène, Prof, Pott, Christiane, MD, Hiddemann, Wolfgang, Prof, Unterhalt, Michael, PhD, Dreyling, Martin, Prof

Volltext

Rituximab versus a watch-and-wait approach in patients with advanced-stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trial von Ardeshna, Kirit M, Dr, Qian, Wendi, PhD, Smith, Paul, MSc, Braganca, Nivette, MSc, Lowry, Lisa, FRCPath, Patrick, Pip, PhD, Warden, June, MSc, Stevens, Lindsey, Pocock, Christopher F E, PhD, Miall, Fiona, MD, Cunningham, David, Prof, Davies, John, FRCP, Jack, Andrew, FRCP, Stephens, Richard, MA, Walewski, Jan, MD, Ferhanoglu, Burhan, Prof, Bradstock, Ken, Prof, Linch, David C, Prof

Volltext

CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThe... von Pfreundschuh, Michael, Prof, Kuhnt, Evelyn, MSc, Trümper, Lorenz, Prof, Österborg, Anders, Prof, Trneny, Marek, Prof, Shepherd, Lois, MD, Gill, Devinder S, MD, Walewski, Jan, MD, Pettengell, Ruth, Prof, Jaeger, Ulrich, Prof, Zinzani, Pier-Luigi, MD, Shpilberg, Ofer, Prof, Kvaloy, Stein, Prof, de Nully Brown, Peter, MD, Stahel, Rolf, MD, Milpied, Noel, Prof, López-Guillermo, Armando, MD, Poeschel, Viola, MD, Grass, Sandra, MD, Loeffler, Markus, Prof, Murawski, Niels, MD

Volltext

Rituximab Purging and/or Maintenance in Patients Undergoing Autologous Transplantation for Relapsed Follicular Lymphoma: A Prospective Randomized Trial From the Lymphoma Working Pa... von PETTENGELL, Ruth, SCHMITZ, Norbert, TO, Bik, GEISLER, Christian H, SCHOTS, Rik, KIMBY, Eva, TAVERNA, Christian J, KOZAK, Tomáš, DREGER, Peter, UDDIN, Ruzena, DE ELVIRA, Carmen Ruiz, GOLDSTONE, Anthony H, GISSELBRECHT, Christian, SMITH, Graeme, PATTON, William N, METZNER, Bernd, CABALLERO, Dolores, TILLY, Herve, WALEWSKI, Jan A, BENCE-BRUCKLER, Isabelle

Volltext

Lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma (MCL-002; SPRINT): a phase 2, randomised, multicentre trial von Trněný, Marek, Prof, Lamy, Thierry, Prof, Walewski, Jan, Prof, Belada, David, MD, Mayer, Jiri, MD, Radford, John, Prof, Jurczak, Wojciech, MD, Morschhauser, Franck, Prof, Alexeeva, Julia, MD, Rule, Simon, Prof, Afanasyev, Boris, Prof, Kaplanov, Kamil, MD, Thyss, Antoine, Prof, Kuzmin, Alexej, MD, Voloshin, Sergey, MD, Kuliczkowski, Kazimierz, Prof, Giza, Agnieszka, MD, Milpied, Noel, Prof, Stelitano, Caterina, MD, Marks, Reinhard, MD, Trümper, Lorenz, Prof, Biyukov, Tsvetan, MD, Patturajan, Meera, PhD, Bravo, Marie-Laure Casadebaig, MSc, Arcaini, Luca, Prof

Volltext

First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma: results of a phase 1/2 trial von Hagenbeek, Anton, Gadeberg, Ole, Johnson, Peter, Møller Pedersen, Lars, Walewski, Jan, Hellmann, Andrzej, Link, Brian K., Robak, Tadeusz, Wojtukiewicz, Marek, Pfreundschuh, Michael, Kneba, Michael, Engert, Andreas, Sonneveld, Pieter, Flensburg, Mimi, Petersen, Jørgen, Losic, Nedjad, Radford, John

Volltext

Chemotherapy plus Involved-Field Radiation in Early-Stage Hodgkin's Disease von Fermé, Christophe, Eghbali, Houchingue, Meerwaldt, Jacobus H, Rieux, Chantal, Bosq, Jacques, Berger, Françoise, Girinsky, Théodore, Brice, Pauline, van't Veer, Mars B, Walewski, Jan A, Lederlin, Pierre, Tirelli, Umberto, Carde, Patrice, Van Den Neste, Eric, Gyan, Emmanuel, Monconduit, Mathieu, Diviné, Marine, Raemaekers, John M.M, Salles, Gilles, Noordijk, Evert M, Creemers, Geert-Jan, Gabarre, Jean, Hagenbeek, Anton, Reman, Oumédaly, Blanc, Michel, Thomas, José, Vié, Brigitte, Kluin-Nelemans, Johanna C, Viseu, Fernando, Baars, Joke W, Poortmans, Philip, Lugtenburg, Pieternella J, Carrie, Christian, Jaubert, Jérôme, Henry-Amar, Michel

Volltext

Primary Mediastinal Large B-cell Lymphoma von Dabrowska-Iwanicka, Anna, Walewski, Jan A.

Volltext

Improving outcomes after autologous transplantation in relapsed/refractory Hodgkin lymphoma: a European expert perspective von Sureda, Anna, Andre, Marc, Borchmann, Peter, da Silva, Maria G., Gisselbrecht, Christian, Vassilakopoulos, Theodoros P., Zinzani, Pier Luigi, Walewski, Jan

Volltext

New molecular targets in Hodgkin and Reed-Sternberg cells von Sadaf, Hummaira, Ambroziak, Maciej, Binkowski, Robert, Kluebsoongnoen, Jakkapong, Paszkiewicz-Kozik, Ewa, Steciuk, Jaroslaw, Markowicz, Sergiusz, Walewski, Jan, Sarnowska, Elzbieta, Sarnowski, Tomasz Jacek, Konopinski, Ryszard

Volltext

Microbial and Metabolic Gut Profiling across Seven Malignancies Identifies Fecal Faecalibacillus intestinalis and Formic Acid as Commonly Altered in Cancer Patients von Kulecka, Maria, Czarnowski, Paweł, Bałabas, Aneta, Turkot, Maryla, Kruczkowska-Tarantowicz, Kamila, Żeber-Lubecka, Natalia, Dąbrowska, Michalina, Paszkiewicz-Kozik, Ewa, Walewski, Jan, Ługowska, Iwona, Koseła-Paterczyk, Hanna, Rutkowski, Piotr, Kluska, Anna, Piątkowska, Magdalena, Jagiełło-Gruszfeld, Agnieszka, Tenderenda, Michał, Gawiński, Cieszymierz, Wyrwicz, Lucjan, Borucka, Magdalena, Krzakowski, Maciej, Zając, Leszek, Kamiński, Michał, Mikula, Michał, Ostrowski, Jerzy

Volltext

Aggressive B-cell lymphoma: chasing the target von Walewski, Jan

Volltext

Higher genome variability within metabolism genes associates with recurrent Clostridium difficile infection von Kulecka, Maria, Waker, Edyta, Ambrozkiewicz, Filip, Paziewska, Agnieszka, Skubisz, Karolina, Cybula, Patrycja, Targonski, Lukasz, Mikula, Michal, Walewski, Jan, Ostrowski, Jerzy

Volltext

High efficacy of intensive immunochemotherapy for primary mediastinal B-cell lymphoma with prolonged follow up von Romejko-Jarosinska, Joanna, Ostrowska, Beata, Dabrowska-Iwanicka, Anna, Domanska-Czyz, Katarzyna, Rymkiewicz, Grzegorz, Paszkiewicz-Kozik, Ewa, Konecki, Robert, Borawska, Anna, Druzd-Sitek, Agnieszka, Lampka, Elzbieta, Osiadacz, Wlodzimierz, Osowiecki, Michal, Popławska, Lidia, Swierkowska, Monika, Targonski, Lukasz, Tajer, Joanna, Lapinska, Grazyna, Smorczewska, Malwina, Walewski, Jan

Volltext

High Prevalence of Genetically Related Clostridium Difficile Strains at a Single Hemato-Oncology Ward Over 10 Years von Waker, Edyta, Ambrozkiewicz, Filip, Kulecka, Maria, Paziewska, Agnieszka, Skubisz, Karolina, Cybula, Patrycja, Targoński, Łukasz, Mikula, Michał, Walewski, Jan, Ostrowski, Jerzy

Volltext

Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without ri... von Pfreundschuh, Michael, Prof, Ho, Anthony D, MD, Cavallin-Stahl, Eva, MD, Wolf, Max, Prof, Pettengell, Ruth, Prof, Vasova, Ingrid, MD, Belch, Andrew, MD, Walewski, Jan, MD, Zinzani, Pier-Luigi, MD, Mingrone, Walter, MD, Kvaloy, Stein, MD, Shpilberg, Ofer, Prof, Jaeger, Ulrich, Prof, Hansen, Mads, Prof, Corrado, Claudia, MD, Scheliga, Adriana, MD, Loeffler, Markus, Prof, Kuhnt, Evelyn, Dipl Math

Volltext

Novel monoclonal antibodies for diffuse large B-cell lymphoma von Walewski, Jan

Volltext

Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trial von Coiffier, Bertrand, Prof, Osmanov, Evgenii A, Prof, Hong, Xiaonan, Prof, Scheliga, Adriana, MD, Mayer, Jiri, Prof, Offner, Fritz, Prof, Rule, Simon, MD, Teixeira, Adriana, MD, Walewski, Jan, Prof, de Vos, Sven, MD, Crump, Michael, Prof, Shpilberg, Ofer, Prof, Esseltine, Dixie-Lee, MD, Zhu, Eugene, PhD, Enny, Christopher, BS, Theocharous, Panteli, PhD, van de Velde, Helgi, MD, Elsayed, Yusri A, MD, Zinzani, Pier Luigi, Prof

Volltext